Ambalal Sarabhai [AMBALALSA] vs Gujarat Themis [GUJTHEM] Detailed Stock Comparison

Ambalal Sarabhai Enterprises Ltd.

BSE
Loading...

Gujarat Themis Biosyn Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Ambalal Sarabhai Enterprises Ltd. wins in 8 metrics, Gujarat Themis Biosyn Ltd. wins in 11 metrics, with 0 ties. Gujarat Themis Biosyn Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Ambalal Sarabhai Enterprises Ltd. Gujarat Themis Biosyn Ltd. Better
P/E Ratio (TTM) 23.36 73.73 Ambalal Sarabhai Enterprises Ltd.
Price-to-Book Ratio 1.72 13.36 Ambalal Sarabhai Enterprises Ltd.
Debt-to-Equity Ratio 31.59 27.04 Gujarat Themis Biosyn Ltd.
PEG Ratio 0.62 -17.55 Ambalal Sarabhai Enterprises Ltd.
EV/EBITDA 12.52 52.76 Ambalal Sarabhai Enterprises Ltd.
Profit Margin (TTM) 5.16% 29.99% Gujarat Themis Biosyn Ltd.
Operating Margin (TTM) 10.95% 40.16% Gujarat Themis Biosyn Ltd.
EBITDA Margin (TTM) 10.95% 40.16% Gujarat Themis Biosyn Ltd.
Return on Equity 3.52% 19.64% Gujarat Themis Biosyn Ltd.
Return on Assets (TTM) 1.83% 16.19% Gujarat Themis Biosyn Ltd.
Free Cash Flow (TTM) $-203.34M $-251.22M Ambalal Sarabhai Enterprises Ltd.
Dividend Yield N/A 0.17% N/A
1-Year Return -5.76% 31.69% Gujarat Themis Biosyn Ltd.
Price-to-Sales Ratio (TTM) 1.20 22.23 Ambalal Sarabhai Enterprises Ltd.
Enterprise Value $2.77B $36.09B Gujarat Themis Biosyn Ltd.
EV/Revenue Ratio 1.36 22.65 Ambalal Sarabhai Enterprises Ltd.
Gross Profit Margin (TTM) 41.99% 83.29% Gujarat Themis Biosyn Ltd.
Revenue per Share (TTM) $26 $15 Ambalal Sarabhai Enterprises Ltd.
Earnings per Share (Diluted) $1.36 $4.40 Gujarat Themis Biosyn Ltd.
Beta (Stock Volatility) -0.14 -0.17 Gujarat Themis Biosyn Ltd.

Ambalal Sarabhai Enterprises Ltd. vs Gujarat Themis Biosyn Ltd. Stock Performance Analysis

Loading Price Chart...

AMBALALSA
GUJTHEM

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Ambalal Sarabhai Enterprises Ltd.-3.15%14.81%14.78%47.15%31.73%28.76%
Gujarat Themis Biosyn Ltd.1.72%7.42%6.10%33.40%-1.19%-10.34%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Ambalal Sarabhai Enterprises Ltd.-5.76%68.27%-36.94%323.87%381.00%225.94%
Gujarat Themis Biosyn Ltd.31.69%84.69%84.69%84.69%84.69%84.69%

Performance & Financial Health Analysis: Ambalal Sarabhai Enterprises Ltd. vs Gujarat Themis Biosyn Ltd.

MetricAMBALALSAGUJTHEM
Market Information
Market Cap i₹2.43B₹35.41B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i84,06179,452
90 Day Avg. Volume i120,526106,446
Last Close₹36.03₹401.80
52 Week Range₹23.12 - ₹38.85₹225.05 - ₹479.00
% from 52W High-7.26%-16.12%
All-Time High₹77.70 (Jul 08, 2024)₹479.00 (Oct 27, 2025)
% from All-Time High-53.63%-16.12%
Growth Metrics
Quarterly Revenue Growth0.13%0.10%
Quarterly Earnings Growth0.37%-0.04%
Financial Health
Profit Margin (TTM) i0.05%0.30%
Operating Margin (TTM) i0.11%0.40%
Return on Equity (TTM) i0.04%0.20%
Debt to Equity (MRQ) i31.5927.04
Cash & Liquidity
Book Value per Share (MRQ)₹18.44₹24.29
Cash per Share (MRQ)₹1.73₹0.92
Operating Cash Flow (TTM) i₹-299,709,000₹970.68M
Levered Free Cash Flow (TTM) i₹49.31M₹487.72M
Dividends
Last 12-Month Dividend Yield iN/A0.17%
Last 12-Month Dividend iN/A₹0.67

Valuation & Enterprise Metrics Analysis: Ambalal Sarabhai Enterprises Ltd. vs Gujarat Themis Biosyn Ltd.

MetricAMBALALSA (Apr 24, 2026)GUJTHEM (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i23.3673.73
Forward P/E iN/AN/A
PEG Ratio i0.62-17.55
Price to Sales (TTM) i1.2022.23
Price to Book (MRQ) i1.7213.36
Market Capitalization
Market Capitalization i₹2.43B₹35.41B
Enterprise Value i₹2.77B₹36.09B
Enterprise Value Metrics
Enterprise to Revenue i1.3622.65
Enterprise to EBITDA i12.5252.76
Risk & Other Metrics
Beta i-0.14-0.17
Book Value per Share (MRQ) i₹18.44₹24.29

Financial Statements Comparison: Ambalal Sarabhai Enterprises Ltd. vs Gujarat Themis Biosyn Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricAMBALALSA (2025)GUJTHEM (2025)
Revenue/Sales i1.95B1.51B
Cost of Goods Sold i1.23B318.78M
COGS % of Revenue i62.9%21.1%
Gross Profit i723.71M1.19B
Gross Margin i37.1%78.9%
Research & Development i165,00034.37M
Operating Income (EBIT) i92.36M642.49M
Operating Margin i4.7%42.6%
EBITDA i205.00M713.04M
EBITDA Margin i10.5%47.3%
Pre-Tax Income i48.34M655.38M
Pre-Tax Income % of Revenue i2.5%43.5%
Income Tax i-981,000167.66M
Income Tax % of Revenue i-0.1%11.1%
Net Income (Profit) i49.32M487.72M
Profit Margin i2.5%32.3%

Balance Sheet & Liquidity Metrics

MetricAMBALALSA (2025)GUJTHEM (2025)
Cash & Equivalents i48.95M116.94M
Total Current Assets i1.18B519.73M
Total Current Assets % of Revenue i60.7%34.5%
Total Current Liabilities i1.20B205.60M
Total Current Liabilities % of Revenue i61.6%13.6%
Long-Term Debt i90.15M296.36M
Long-Term Debt % of Revenue i4.6%19.7%
Total Shareholders Equity i1.40B2.48B
Retained Earnings i-28.33M2.37B
Retained Earnings % of Revenue i-1.5%157.4%
Property, Plant & Equipment i50.63M411.30M

Cash Flow Statement Comparison

MetricAMBALALSA (2025)GUJTHEM (2025)
Operating Cash Flow i-299.71M970.68M
Operating Cash Flow % of Revenue i-15.3%64.4%
Capital Expenditures i-25.45M-1.16B
Free Cash Flow i-203.34M-251.22M
FCF Margin i-10.4%-16.7%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricAMBALALSAGUJTHEM
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i76.63M108.97M
Float Shares i46.90M29.52M
% Held by Insiders i34.99%71.98%
% Held by Institutions i0.00%1.18%
% Held by Public i65.01%26.84%

Dividend Analysis & Yield Comparison: Ambalal Sarabhai Enterprises Ltd. vs Gujarat Themis Biosyn Ltd.

MetricAMBALALSAGUJTHEM
Last 12-Month Dividend iN/A₹0.67
Last 12-Month Dividend Yield iN/A0.17%
3-Year Avg Annual Dividend iN/A₹0.22
3-Year Avg Dividend Yield iN/A0.17%
3-Year Total Dividends iN/A₹0.67
Ex-Dividend DateN/ASep 04, 2025